The general surgery devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. The pancreatic and biliary stents are thin, tube-such as structures that could be inserted into the bile/pancreatic/hepatic ducts to relieve narrowing of the ducts, this condition is known as biliary structure. GlobalData uses proprietary data and analytics to provide a comprehensive report on the pancreatic and biliary stent devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

In 2021, GlobalData’s Market Model methodology determined that the leading player in the pancreatic and biliary stent market in New Zealand was Boston Scientific followed by W. L. Gore & Associates, ConMed, CR Bard, Cook Medical, Medtronic, Olympus and Cordis.

The pancreatic and biliary stent is used to support a narrowed part of the duct and prevents the reformation of the stricture. This market consists of Metal biliary and Plastic stents. Metal biliary stents are tubular structures made of metal and can be used to treat structures. Plastic stents are composed of polythene, polyurethane, or Teflon and are available in different configurations.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the pancreatic and biliary stent devices market within New Zealand was expected to be over $1m in 2021.

For the latest complete market share analysis of pancreatic and biliary stent device market in New Zealand, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.